Quantcast

Latest Clinical trial Stories

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-17 12:27:03

-- Compass(TM) Up for Technology Innovation Award -- NEWTOWN, Pa., Sept. 17, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced three of its experts are speaking at the 20th Annual SCDM Conference for Clinical Data Management to be held September 28 to October 1 in Las Vegas, Nevada. The Company also announced the innovative Compass technology, a risk-based monitoring solution to raise overall quality in...

2014-09-17 08:29:54

Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens WOONSOCKET, R.I., Sept. 17, 2014 /PRNewswire/ -- An analysis done by the CVS Health Research Institute provides insights regarding patients taking Sovaldi® (sofosbuvir), a new and expensive treatment for Hepatitis C introduced in December. The data shows that over the last several months (May through August 2014) there has been a plateau and actual...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...

2014-09-16 23:12:55

The research team at Avail Clinical is conducting a clinical study to evaluate a new remedy for the common cold. Adults who are experiencing early cold symptoms, but are otherwise healthy, may qualify to participate. DeLand, Florida (PRWEB) September 16, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com/trial/common-cold/) or contact them directly at (386)...

2014-09-16 23:11:40

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial here in Birmingham. Birmingham, Alabama (PRWEB) September 16, 2014 *To find out more about this pneumonia vaccine clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web...

2014-09-16 23:04:40

For the first time, Orange Paper readers will have a detailed snapshot of clinical trials in Ukraine MOSCOW, Russia (PRWEB) September 16, 2014 Synergy Research Group has debuted the Ukraine Orange Paper. The comprehensive report gives the best detail and analysis of the state of clinical trials in Ukraine. Data was pulled from a variety of sources, including Ministry of Health in Ukraine and the FDA, etc. The Ukraine Orange Paper will give readers actionable intelligence on clinical...

2014-09-16 12:31:31

SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY). Denovo gains all rights to develop, manufacture and commercialize enzastaurin globally, including transfer of all intellectual property and other rights, data, and information. http://photos.prnewswire.com/prnvar/20140820/138306 Lilly developed enzastaurin in a variety of indications, including in...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 08:30:30

"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, Md., Sept. 16, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that its DCVax-L is the first product to receive formal designation as a "Promising Innovative Medicine" (PIM) under the new "Early Access to Medicines Scheme" (EAMS) launched in the UK...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related